zolsketil pegylated liposomal
accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.
farmorubicin rd 10 mg solution for injection
pfizer enterprises sarl - Эпирубицин - 10 mg solution for injection
farmorubicin rd 50 mg solution for injection
pfizer enterprises sarl - Эпирубицин - 50 mg solution for injection
farmorubicin pfs 2 mg/ml solution for injection
pfizer enterprises sarl - Эпирубицин - 2 mg/ml solution for injection
epirubicin ebewe 2 mg/ml concentrate for solution for injection/infusion
ebewe pharma ges.m.b.h. nfg.kg - Эпирубицин - 2 mg/ml concentrate for solution for injection/infusion
epirubicin kabi 2 mg/ml solution for injection or infusion
fresenius kabi oncology plc. - Эпирубицин - 2 mg/ml solution for injection or infusion
doxorubicin mylan 2 mg/ml concentrate for solution for infusion
agila specialties uk limited - Доксорубицин - 2 mg/ml concentrate for solution for infusion
doxorubicin mylan 2 mg/ml powder for concentrate for solution for infusion
agila specialties uk limited - Доксорубицин - 2 mg/ml powder for concentrate for solution for infusion
doxorubicin ebewe 2 mg/ml concetrate for solution for infusion
ebewe pharma ges.m.b.h. nfg.kg - Доксорубицин - 2 mg/ml concetrate for solution for infusion
epirubicin mylan 2 mg/ml solution for injection or infusion
mylan s.a.s. - 2 mg/ml solution for injection or infusion